{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T23:56:12Z","timestamp":1703030172016},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,8,10]],"date-time":"2011-08-10T00:00:00Z","timestamp":1312934400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1007\/s00404-011-2014-7","type":"journal-article","created":{"date-parts":[[2011,8,9]],"date-time":"2011-08-09T02:33:56Z","timestamp":1312857236000},"page":"689-697","source":"Crossref","is-referenced-by-count":6,"title":["Diagnosis and therapy of polycystic ovarian syndrome: results of a survey among German gynecologists with a review on literature"],"prefix":"10.1007","volume":"285","author":[{"given":"Ines","family":"Doll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Doll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai J.","family":"Buhling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,10]]},"reference":[{"key":"2014_CR1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","volume":"333","author":"S Franks","year":"1995","unstructured":"Franks S (1995) Polycystic ovary syndrome. N Engl J Med 333:853\u2013861","journal-title":"N Engl J Med"},{"key":"2014_CR2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.bpobgyn.2004.05.001","volume":"18","author":"R Hart","year":"2004","unstructured":"Hart R, Hickey M, Franks S (2004) Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:671\u2013683","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2014_CR3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00404-006-0171-x","volume":"274","author":"I Matalliotakis","year":"2006","unstructured":"Matalliotakis I, Kourtis A, Koukoura O, Panidis D (2006) Polycystic ovary syndrome: etiology and pathogenesis. Arch Gynecol Obstet 274:187\u2013197","journal-title":"Arch Gynecol Obstet"},{"key":"2014_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","volume":"19","author":"ESHRE Rotterdam\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","unstructured":"ESHRE Rotterdam\/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41\u201347","journal-title":"Hum Reprod"},{"key":"2014_CR5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00006254-200211000-00022","volume":"57","author":"JSEM Laven","year":"2002","unstructured":"Laven JSEM, Imani B, Eijkemans MJC, Fauser BCJM (2002) New approach to polycystic ovary syndrome and other forms of anovulatory infertility. Obstet Gynecol Surv 57:755\u2013767","journal-title":"Obstet Gynecol Surv"},{"key":"2014_CR6","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S1521-6934(04)00106-3","volume":"18","author":"IS Fraser","year":"2004","unstructured":"Fraser IS, Kovacs G (2004) Current recommendations for the diagnostic evaluation and follow-up of patients presenting with symptomatic polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:813\u2013823","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2014_CR7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1259\/bjr.75.889.750009","volume":"75","author":"K Lakhani","year":"2002","unstructured":"Lakhani K, Seifalian AM, Atiomo WU, Hardiman P (2002) Polycystic ovaries. Br J Radiol 75:9\u201316","journal-title":"Br J Radiol"},{"key":"2014_CR8","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1210\/jc.82.7.2248","volume":"82","author":"AE Taylor","year":"1997","unstructured":"Taylor AE, McCourt B, Martin KA et al (1997) Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 82:2248\u20132256","journal-title":"J Clin Endocrinol Metab"},{"key":"2014_CR9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/jcem-68-1-173","volume":"68","author":"R Pasquali","year":"1989","unstructured":"Pasquali R, Antenucci D, Casimirri F et al (1989) Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab 68:173\u2013179","journal-title":"J Clin Endocrinol Metab"},{"key":"2014_CR10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1365-2265.1992.tb02909.x","volume":"36","author":"DS Kiddy","year":"1992","unstructured":"Kiddy DS, Hamilton-Fairley D, Bush A et al (1992) Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome. Clin Endocrinol (Oxf) 36:105\u2013111","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2014_CR11","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1093\/humrep\/16.6.1255","volume":"16","author":"S Kirchengast","year":"2001","unstructured":"Kirchengast S, Huber J (2001) Body composition characteristics and body fat distribution in lean women with polycystic ovary syndrome. Hum Reprod 16:1255\u20131260","journal-title":"Hum Reprod"},{"key":"2014_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9378(15)30642-6","volume":"29","author":"IF Stein","year":"1935","unstructured":"Stein IF, Leventhal ML (1935) Amenorrhea associated with bilateral polycystic ovaries. Am J Obstet Gynecol 29:181\u2013191","journal-title":"Am J Obstet Gynecol"},{"key":"2014_CR13","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1210\/jc.2003-030617","volume":"88","author":"ME Silfen","year":"2003","unstructured":"Silfen ME, Denburg MR, Manibo AM et al (2003) Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. J Clin Endocrinol Metab 88:4682\u20134688","journal-title":"J Clin Endocrinol Metab"},{"key":"2014_CR14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.bpobgyn.2004.05.003","volume":"18","author":"L Moran","year":"2004","unstructured":"Moran L, Norman RJ (2004) Understanding and managing disturbances in insulin metabolism and body weight in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:719\u2013736","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2014_CR15","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1161\/01.ATV.15.7.821","volume":"15","author":"E Talbott","year":"1995","unstructured":"Talbott E, Guzick D, Clerici A et al (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arterioscler Thromb Vasc Biol 15:821\u2013826","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2014_CR16","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1210\/jc.84.1.165","volume":"84","author":"RS Legro","year":"1999","unstructured":"Legro RS, Kunselman AR, Dodson WC, Dunaif A (1999) Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 84:165\u2013169","journal-title":"J Clin Endocrinol Metab"},{"key":"2014_CR17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.2337\/diacare.25.7.1217","volume":"25","author":"J Vrbikova","year":"2002","unstructured":"Vrbikova J, Bendlova B, Hill M, Vankova M, Vondra K, Starka L (2002) Insulin sensitivity and beta-cell function in women with polycystic ovary syndrome. Diabetes Care 25:1217\u20131222","journal-title":"Diabetes Care"},{"issue":"Suppl 8A","key":"2014_CR18","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/j.amjmed.2003.08.012","volume":"115","author":"JR Sowers","year":"2003","unstructured":"Sowers JR (2003) Obesity as a cardiovascular risk factor. Am J Med 115(Suppl 8A):37S\u201341S","journal-title":"Am J Med"},{"key":"2014_CR19","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1210\/jc.2003-030562","volume":"88","author":"S Elsenbruch","year":"2003","unstructured":"Elsenbruch S, Hahn S, Kowalsky D et al (2003) Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:5801\u20135807","journal-title":"J Clin Endocrinol Metab"},{"key":"2014_CR20","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.bpobgyn.2004.05.005","volume":"18","author":"FR Cattrall","year":"2004","unstructured":"Cattrall FR, Healy DL (2004) Long-term metabolic, cardiovascular and neoplastic risks with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:803\u2013812","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2014_CR21","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1055\/s-2003-43304","volume":"21","author":"RS Legro","year":"2003","unstructured":"Legro RS (2003) Diagnostic criteria in polycystic ovary syndrome. Semin Reprod Med 21:267\u2013275","journal-title":"Semin Reprod Med"},{"key":"2014_CR22","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.bpobgyn.2004.05.007","volume":"18","author":"JS Archer","year":"2004","unstructured":"Archer JS, Chang RJ (2004) Hirsutism and acne in polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:737\u2013754","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2014_CR23","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00129-005-1673-5","volume":"38","author":"AN Sch\u00fcring","year":"2005","unstructured":"Sch\u00fcring AN, Kiesel L (2005) Hormonelle Therapie des polyzystischen Ovarsyndroms (PLOS). Gyn\u00e4kologe 38:333\u2013341","journal-title":"Gyn\u00e4kologe"},{"key":"2014_CR24","unstructured":"Graf M (2006) CME Praktische Fortbildung\u2014Gyn\u00e4kologie, Geburtsmedizin und Gyn\u00e4kologische Endokrinologie, akademos Wissenschaftsverlag, Hamburg, Germany 3"},{"key":"2014_CR25","doi-asserted-by":"crossref","first-page":"2706","DOI":"10.1093\/humrep\/13.10.2706","volume":"13","author":"E Dahlgren","year":"1998","unstructured":"Dahlgren E, Landin K, Krotkiewski M, Holm G, Janson PO (1998) Effects of two antiandrogen treatments on hirsutism and insulin sensitivity in women with polycystic ovary syndrome. Hum Reprod 13:2706\u20132711","journal-title":"Hum Reprod"},{"key":"2014_CR26","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/S0029-7844(02)02725-4","volume":"101","author":"R Azziz","year":"2003","unstructured":"Azziz R (2003) The evaluation and management of hirsutism. Obstet Gynecol 101:995\u20131007","journal-title":"Obstet Gynecol"},{"key":"2014_CR27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.contraception.2008.10.010","volume":"79","author":"E Palombo-Kinne","year":"2009","unstructured":"Palombo-Kinne E, Schellschmidt I, Schumacher U, Graser T (2009) Efficacy of a combined oral contraceptive containing 0.030\u00a0mg ethinylestradiol\/2\u00a0mg dienogest for the treatment of papulopustular acne in comparison with placebo and 0.035\u00a0mg ethinylestradiol\/2\u00a0mg cyproterone acetate. Contraception 79:282\u2013289","journal-title":"Contraception"},{"key":"2014_CR28","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/j.0001-6349.2004.00481.x","volume":"83","author":"AM Saleh","year":"2004","unstructured":"Saleh AM, Khalil HS (2004) Review of nonsurgical and surgical treatment and the role of insulin-sensitizing agents in the management of infertile women with polycystic ovary syndrome. Acta Obstet Gynecol Scand 83:614\u2013621","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"5","key":"2014_CR29","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bpobgyn.2004.05.006","volume":"18","author":"R Homburg","year":"2004","unstructured":"Homburg R (2004) Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynecol 18(5):773\u2013788","journal-title":"Best Pract Res Clin Obstet Gynecol"},{"key":"2014_CR30","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00404-003-0537-2","volume":"270","author":"M Al-Azemi","year":"2004","unstructured":"Al-Azemi M, Omu FE, Omu AE (2004) The effect of obesity on the outcome of infertility management in women with polycystic ovary syndrome. Arch Gynecol Obstet 270:205\u2013210","journal-title":"Arch Gynecol Obstet"},{"key":"2014_CR31","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1093\/humrep\/10.suppl_1.31","volume":"10","author":"AM Clark","year":"1995","unstructured":"Clark AM, Ledger W, Galletly C et al (1995) Weight loss results in significant improvement in pregnancy and ovulation rates in anovulatory obese women. Hum Reprod 10:2705\u20132712","journal-title":"Hum Reprod"},{"key":"2014_CR32","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/humrep\/deg367","volume":"18","author":"PG Crosignani","year":"2003","unstructured":"Crosignani PG, Colombo M, Vegetti W, Somigliana E, Gessati A, Ragni G (2003) Overweight and obese anovulatory patients with polycystic ovaries: parallel improvements in anthropometric indices, ovarian physiology and fertility rate induced by diet. Hum Reprod 18:1928\u20131932","journal-title":"Hum Reprod"},{"key":"2014_CR33","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.bpobgyn.2004.05.006","volume":"18","author":"R Homburg","year":"2004","unstructured":"Homburg R (2004) Management of infertility and prevention of ovarian hyperstimulation in women with polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol 18:773\u2013788","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2014_CR34","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1093\/humrep\/deh530","volume":"19","author":"S Muth","year":"2004","unstructured":"Muth S, Norman J, Sattar N, Fleming R (2004) Women with polycystic ovary syndrome (PCOS) often undergo protracted treatment with metformin and are disinclined to stop: indications for a change in licensing arrangements? Hum Reprod 19:2718\u20132720","journal-title":"Hum Reprod"},{"key":"2014_CR35","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1530\/eje.0.1470217","volume":"147","author":"CJ Kelly","year":"2002","unstructured":"Kelly CJ, Gordon D (2002) The effect of metformin on hirsutism in polycystic ovary syndrome. Eur J Endocrinol 147:217\u2013221","journal-title":"Eur J Endocrinol"},{"key":"2014_CR36","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1055\/s-2004-824847","volume":"129","author":"S Hahn","year":"2004","unstructured":"Hahn S, Quadbeck B, Elsenbruch S et al (2004) Metformin, an efficacious drug in the treatment of polycystic ovary syndrome. Dtsch Med Wochenschr 129:1059\u20131064","journal-title":"Dtsch Med Wochenschr"},{"key":"2014_CR37","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","volume":"88","author":"L Harborne","year":"2003","unstructured":"Harborne L, Fleming R, Lyall H, Sattar N, Norman J (2003) Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome. J Clin Endocrinol Metab 88:4116\u20134123","journal-title":"J Clin Endocrinol Metab"},{"key":"2014_CR38","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09513590410001729194","volume":"19","author":"PM Lam","year":"2004","unstructured":"Lam PM, Cheung LP, Haines C (2004) Revisit of metformin treatment in polycystic ovarian syndrome. Gynecol Endocrinol 19:33\u201339","journal-title":"Gynecol Endocrinol"},{"key":"2014_CR39","doi-asserted-by":"crossref","unstructured":"Tang T, Lord JM, Norman RJ, Yasmin E, Balen AH (2010) Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility Cochrane Database Syst Rev (1). Report. doi: 10.1002\/14651858.CD003053.pub4","DOI":"10.1002\/14651858.CD003053.pub4"},{"key":"2014_CR40","first-page":"1","volume":"66","author":"KJ B\u00fchling","year":"2006","unstructured":"B\u00fchling KJ, Bartley J, L\u00fcbbert H (2006) Einsatz oraler Antidiabetika in der Therapie des Kinderwunsches, des Gestationsdiabetes und zur Pr\u00e4vention des Typ-2- Diabetes. Geb Fra 66:1\u20135","journal-title":"Geb Fra"},{"key":"2014_CR41","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S0015-0282(99)00208-3","volume":"72","author":"V Leo De","year":"1999","unstructured":"De Leo V, la Marca A, Ditto A, Morgante G, Cianci A (1999) Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil Steril 72:282\u2013285","journal-title":"Fertil Steril"},{"key":"2014_CR42","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJM199806253382603","volume":"338","author":"JE Nestler","year":"1998","unstructured":"Nestler JE, Jakubowicz DJ, Evans WS, Pasquali R (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N Engl J Med 338:1876\u20131880","journal-title":"N Engl J Med"},{"key":"2014_CR43","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0015-0282(01)02963-6","volume":"77","author":"JE Nestler","year":"2002","unstructured":"Nestler JE, Stovall D, Akhter N, Iuorno MJ, Jakubowicz DJ (2002) Strategies for the use of insulin-sensitizing drugs to treat infertility in women with polycystic ovary syndrome. Fertil Steril 77:209\u2013215","journal-title":"Fertil Steril"},{"key":"2014_CR44","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1210\/jc.2005-0110","volume":"90","author":"S Palomba","year":"2005","unstructured":"Palomba S, Orio F Jr, Falbo A et al (2005) Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome. J Clin Endocrinol Metab 90:4068\u20134074","journal-title":"J Clin Endocrinol Metab"},{"key":"2014_CR45","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/0029-7844(96)00190-1","volume":"88","author":"SL Tan","year":"1996","unstructured":"Tan SL, Farhi J, Homburg R, Jacobs HS (1996) Induction of ovulation in clomiphene-resistant polycystic ovary syndrome with pulsatile GnRH. Obstet Gynecol 88:221\u2013226","journal-title":"Obstet Gynecol"},{"key":"2014_CR46","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1471-0528.1998.tb10097.x","volume":"105","author":"TC Li","year":"1998","unstructured":"Li TC, Saravelos H, Chow MS, Chisabingo R, Cooke ID (1998) Factors affecting the outcome of laparoscopic ovarian drilling for polycystic ovarian syndrome in women with anovulatory infertility. Br J Obstet Gynaecol 105:338\u2013344","journal-title":"Br J Obstet Gynaecol"},{"key":"2014_CR47","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1210\/jc.83.7.2361","volume":"83","author":"B Imani","year":"1998","unstructured":"Imani B, Eijkemans MJ, te Velde ER, Habbema JD, Fauser BC (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83:2361\u20132365","journal-title":"J Clin Endocrinol Metab"},{"key":"2014_CR48","doi-asserted-by":"crossref","unstructured":"Farquhar C, Lilford RJ, Marjoribanks J, Vandekerckhove P (2005) Laparoscopic \u201cdrilling\u201d by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev CD001122","DOI":"10.1002\/14651858.CD001122.pub2"},{"key":"2014_CR49","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/09513599309152479","volume":"7","author":"J Verhelst","year":"1993","unstructured":"Verhelst J, Gerris J, Joostens M, Van der Meer S, Van Royen E, Mahler C (1993) Clinical and endocrine effects of laser vaporization in patients with polycystic ovarian disease. Gynecol Endocrinol 7:49\u201355","journal-title":"Gynecol Endocrinol"},{"key":"2014_CR50","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0015-0282(16)57904-7","volume":"64","author":"J Farhi","year":"1995","unstructured":"Farhi J, Soule S, Jacobs HS (1995) Effect of laparoscopic ovarian electrocautery on ovarian response and outcome of treatment with gonadotropins in clomiphene citrate-resistant patients with polycystic ovary syndrome. Fertil Steril 64:930\u2013935","journal-title":"Fertil Steril"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-011-2014-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00404-011-2014-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-011-2014-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,13]],"date-time":"2019-06-13T18:45:26Z","timestamp":1560451526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00404-011-2014-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8,10]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["2014"],"URL":"https:\/\/doi.org\/10.1007\/s00404-011-2014-7","relation":{},"ISSN":["0932-0067","1432-0711"],"issn-type":[{"value":"0932-0067","type":"print"},{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8,10]]}}}